New therapies for pneumonia
1Institut National de la Santé ET de la Recherche Médicale, Unité U722, UFR de Médecine, Université Paris Diderot, PRES Sorbonne Paris Cité, Paris, France. jean-damien.ricard@lmr.aphp.fr
Purpose Of Review:
Acute respiratory tract infections are a key public health problem, and represent a major cause of death worldwide. The dramatic shortage of new antibiotics combined with the increasing number of antibiotic-resistant bacteria constitutes a worrisome threat for the global population and a critical challenge for healthcare institutions. Over recent years, a better understanding of bacterial growth, metabolism, and virulence has offered several potential targets for nonantibiotic antimicrobial therapies.
Recent Findings:
Several leads have been investigated, targeting adhesion, communication, toxins, virulence factors, direct bacterial killing by bacteriophages, and vaccine strategies. Promising results have been obtained with these different targets, including inhibition of quorum sensing, use of pilicide compounds to inhibit bacterial adhesion, prevention and treatment of Pseudomonas aeruginosa pneumonia by bacteriophages, effective protection against P. aeruginosa lung infection with mucosal vaccination, use of anti-PcrV antibodies in P. aeruginosa-induced sepsis.
Summary:
Expectations are high regarding the translation of these experimental results into true clinical benefits for the patients. Importantly, clinical studies are ongoing in some areas, and promising preliminary results have already been obtained in some instances.
Insights
New nonantibiotic therapies show promise for treating acute respiratory infections caused by antibiotic-resistant bacteria. Research targets bacterial adhesion, communication, and virulence, with ongoing clinical studies yielding encouraging results.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Acute respiratory tract infections (ARTIs) are a major global health concern, leading to significant mortality.
- The rise of antibiotic-resistant bacteria, coupled with a scarcity of new antibiotics, poses a critical threat to public health.
- Understanding bacterial pathogenesis provides novel targets for antimicrobial strategies beyond traditional antibiotics.
Purpose of the Study:
- To review emerging nonantibiotic antimicrobial therapies for ARTIs.
- To explore novel therapeutic targets in bacterial growth, metabolism, and virulence.
- To assess the potential of these strategies in combating antibiotic resistance.
Main Methods:
- Review of experimental leads targeting bacterial adhesion, communication, toxins, and virulence factors.
- Investigation of bacteriophage therapy and vaccine strategies.
- Analysis of preclinical and early clinical data for nonantibiotic approaches.
Main Results:
- Promising results in inhibiting bacterial quorum sensing and adhesion using pilicides.
- Successful prevention and treatment of Pseudomonas aeruginosa pneumonia with bacteriophages.
- Effective protection against P. aeruginosa lung infections via mucosal vaccination and anti-PcrV antibodies.
Conclusions:
- Nonantibiotic therapies demonstrate significant potential for clinical translation in treating ARTIs.
- Ongoing clinical studies are evaluating these novel approaches.
- Early findings suggest these strategies could offer viable alternatives to antibiotics against resistant pathogens.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:14Atypical Pneumonia
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia I: Introduction